Rating History for Aktis Oncology (AKTS) by Leerink

More Stocks Rated by Leerink | Latest Ratings for AKTS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/3/2026 Jonathan Chang New Coverage Outperform
(N/A)		 31.00
(N/A)		 21.98
(29.44)		 33.94% Details